Sumitomo Mitsui Trust Holdings, Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 2 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Holdings, Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$35,478,066
-12.0%
1,388,574
-1.2%
0.03%
-6.5%
Q2 2023$40,293,450
+18.3%
1,404,932
-1.2%
0.03%
+24.0%
Q1 2023$34,069,160
+38.6%
1,421,325
-1.9%
0.02%
+31.6%
Q4 2022$24,576,058
+13.6%
1,449,060
-0.7%
0.02%
+5.6%
Q3 2022$21,629,000
-4.3%
1,459,415
+1.6%
0.02%
+5.9%
Q2 2022$22,606,000
-40.2%
1,436,194
+2.4%
0.02%
-32.0%
Q1 2022$37,800,000
-24.8%
1,402,078
+3.3%
0.02%
-19.4%
Q4 2021$50,240,000
-22.6%
1,357,472
-0.1%
0.03%
-22.5%
Q3 2021$64,911,000
+57.9%
1,358,532
+11.8%
0.04%
+66.7%
Q2 2021$41,112,000
+215.2%
1,214,901
+284.7%
0.02%
+200.0%
Q1 2021$13,043,000
+123.4%
315,812
+134.6%
0.01%
+100.0%
Q4 2020$5,839,000
+3.8%
134,604
+2.6%
0.00%0.0%
Q3 2020$5,627,000
-17.7%
131,170
-10.4%
0.00%
-20.0%
Q2 2020$6,840,000
+97.3%
146,352
-42.6%
0.01%
+66.7%
Q1 2020$3,466,000
+13.6%
255,066
-9.1%
0.00%
+50.0%
Q4 2019$3,050,000
-0.5%
280,548
-6.0%
0.00%
-33.3%
Q3 2019$3,066,000
+149.9%
298,530
+129.7%
0.00%
+200.0%
Q2 2019$1,227,000129,9740.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2023
NameSharesValueWeighting ↓
SEVEN EIGHT CAPITAL, LP 46,819$2,031,0000.47%
Orbimed Advisors 1,206,886$49,844,0000.47%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 25,000$1,033,0000.40%
ARK Investment Management 3,331,889$137,607,0000.27%
FEDERATED HERMES, INC. 3,203,000$132,284,0000.26%
MGO ONE SEVEN LLC 26,990$1,114,0000.19%
Koss-Olinger Consulting, LLC 20,000$826,0000.14%
Jump Financial, LLC 35,400$1,462,0000.14%
Graham Capital Management, L.P. 74,262$3,067,0000.14%
New England Research & Management, Inc. 6,005$248,0000.14%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders